Find latest Myeloma videos · 500+ videos
Dana-Farber Cancer Institute
P

FDA Approval of Isatuximab in 1L MM: Perspectives for Practice

By Dana-Farber Cancer Institute FEATURING Paul Richardson
By Dana-Farber Cancer Institute FEATURING Paul Richardson
933 views
November 12, 2024
Comments 1
Login to view comments. Click here to Login

Related Videos

21:06

ASH 2024 Summary: Myeloma Highlights and Impact on Practice

2024 ASH Annual Meeting Insights Hub

H. Hashmi

1.2K views
28:15

ASH 2024 Review: Key Multiple Myeloma Abstracts

Cleveland Clinic Taussig Cancer Institute

N. Callander

377 views
19:28

ASH 2024 Summary: Multiple Myeloma Highlights and Clinical Implicati…

2024 ASH Annual Meeting Insights Hub

S. Al Hadidi

420 views
04:55

ASH 2024 Insights: Dara vs. Len Maintenance in NDMM - Interim Result…

2024 ASH Annual Meeting Insights Hub

U. Shah

218 views
21:05

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

4.7K views
15:35

Multiple Myeloma: Not as Simple as "CRAB" Anymore

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

R. Banerjee

760 views
09:15

ASH 2024 Summary: Transplant in Myeloma - Key Factors in Decision-Ma…

2024 ASH Annual Meeting Insights Hub

A. Perrot

172 views
19:38

Fast Five Key Updates in Malignant Heme: Pearls From a Pharmacist

Total Health

S. Medeiros

280 views
17:52

2024 Updates on Emerging & Current Treatment of Multiple Myeloma

Indy Hematology Review

K. Anderson

1.3K views
35:27

Advances in Multiple Myeloma 2024: From Bench to Bedside

Dana-Farber Cancer Institute

K. Anderson

724 views
24:35

ASCO® 2024 Summary: "The Best of Myeloma - Review of the Top 5 Abstr…

2024 ASCO® Annual Meeting Insights Hub

H. Hashmi

655 views
21:41

Multiple Myeloma: Hot Topics in 2024

Yale Cancer Center

S. Browning

221 views
06:06

New

The Future of NDMM Treatment: Ongoing Trials and Key ASH 2024 Oral A…

University of Miami Sylvester Comprehensive Cancer Center

O. Landgren

88 views
30:09

New

Expert Roundtable: Future Directions in Managing NDMM - MRD, CAR-T, …

MyCancerHaven

R. Vij, P. Kapoor, M. Alsina, S. Mailankody, A. Nooka, S. Tuchman

111 views
28:46

New

Updates on Managing NDMM in 2024

Louisville Hematology Highlights

S. Usmani

112 views
13:32

ASH 2024 Insights: Analyses of MRD Negativity Dynamics in the Phase …

2024 ASH Annual Meeting Insights Hub

R. Orlowski

121 views
22:33

Treatment Strategies for R/R MM After Frontline Anti-CD38 Therapy

Integrity CE

S. Usmani, J. Hillengass

243 views
20:23

When to Consider Bispecific and CAR-T Therapy in MM

SOHO Brazil 2024

N. S. Raje

429 views
10:57

Indefinite Treatment of Multiple Myeloma: Strategies for Frail Patie…

Shaji Kumar

116 views
13:07

New

Debate: The Relevance of Auto SCT for NDMM

Louisville Hematology Highlights

K. Patel, S. Usmani

95 views
AUTOPLAY